XML 36 R2.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Balance Sheets (USD $)
Sep. 30, 2011
Mar. 31, 2011
ASSETS  
Cash$ 45,579$ 15,704
Deferred financing costs110,193157,732
Note receivable 200,000
Interest receivable 7,096
Prepaid expenses and other current assets18,41329,711
Total current assets174,185410,243
Property and equipment, net4,3297,785
Patents and patents pending, net135,399139,981
Deposits9,2109,210
Total assets323,123567,219
LIABILITIES AND STOCKHOLDERS' DEFICIT  
Accounts payable410,655308,413
Due to related parties617,570617,570
Notes payable594,796190,000
Convertible notes payable, net of discounts2,335,0442,181,852
Derivative liabilities1,341,7262,002,896
Accrued liquidated damages437,800437,800
Other current liabilities924,521804,386
Total current liabilities6,662,1126,542,917
Commitments and Contingencies (Note 12)  
Common stock, par value $0.001 per share; 250,000,000 shares authorized as of September 30, 2011 and March 31, 2011; 100,995,917 and 77,467,361 shares issued and outstanding as of September 30, 2011 and March 31, 2011, respectively100,99877,469
Additional paid-in capital45,071,33642,418,778
Deficit accumulated during development stage(51,511,323)(48,471,945)
Total stockholders’ deficit(6,338,989)(5,975,698)
Total liabilities and stockholders' deficit$ 323,123$ 567,219